outcomes of patients with myeloma receiving fixed-duration cevostamab
Published 1 year ago • 112 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:38
outcomes for patients with multiple myeloma who have had first-line monoclonal antibody exposure
-
1:25
predictors and outcomes of extramedullary disease in multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma
-
8:10
explain secretome aposec
-
1:46:07
hematology lecture
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
2:22
outcomes and management of patients with r/r myeloma who progress on bispecific antibodies
-
1:05
using machine learning to predict the outcomes of patients with ndmm being treated with vrd
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
1:37
predictors of unsustained mrd negativity in transplant-eligible patients with multiple myeloma
-
8:57
outcomes of sct in t-all and t-lbl
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
1:59
outcomes from myeloma xi - what do the results tell us?
-
2:44
myeloma qol through induction and maintenance
-
1:53
phase i trial evaluating a gamma secretase inhibitor in combination with car-t cells in r/r myeloma
-
2:19
how cutting-edge research is changing outcomes in myeloma and the need for novel endpoints in trials
-
3:05
identifying new therapeutic targets on the surfaceome of myeloma plasma cells with proteomics
-
2:41
an overview of the latest advances in hematology